Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Amyotrophic lateral sclerosis]

¹Department of Neurology, Hokkaido University School of Medicine, Sapporo, Japan.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science

|January 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A case of acute urinary retention caused by periaqueductal grey lesion.

Journal of neurology, neurosurgery, and psychiatry·2004

Same author

Mexiletine on segmental hyperhidrosis.

Journal of neurology, neurosurgery, and psychiatry·2002

Same author

[The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].

Rinsho shinkeigaku = Clinical neurology·2001

Same author

Reversal of HIV-associated motor neuron syndrome after highly active antiretroviral therapy.

Journal of neurology·2001

Same author

[Diagnostic criteria for Parkinson's disease].

Nihon rinsho. Japanese journal of clinical medicine·2000

Same author

[Low cerebrospinal fluid pressure syndrome].

Ryoikibetsu shokogun shirizu·2000

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease. Current research explores its causes and treatments, with riluzole showing survival benefits.

Area of Science:

Neurology
Neuroscience
Pathogenesis research

Context:

Amyotrophic lateral sclerosis (ALS) involves motor neuron degeneration.
Understanding ALS pathogenesis is advancing.
Familial ALS linked to superoxide dismutase mutations.

Purpose:

Discuss recent advances in ALS pathogenesis.
Review current therapeutic trials for ALS.
Highlight riluzole's survival advantage.

Summary:

Investigates the role of autoimmunity, glutamate excitotoxicity, and neurotrophic factors in ALS.
Examines therapeutic strategies based on putative ALS pathogenesis.
Riluzole, an antiglutamate agent, demonstrated survival benefits in a randomized controlled trial.

Related Experiment Videos

Impact:

Provides an overview of current ALS research.
Informs understanding of ALS pathogenesis and treatment.
Supports evidence-based clinical practice for ALS management.